NCi Advisors Approve New SPORE Grant Program In Cancer Communications.
ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.
Saul Rivin Receives ACCC Clinical Research Award.
Peters Replaced As Director Of Karmanos Cancer Center.
Clinton Signs Bill Creating NIH Center On Minority Health.
Roswell Park, Karmanos Read The Cancer Letter Interactive.
KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.
NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.
Firm To Collaborate With R. W. Johnson On Vaccines.
Isis 3521 Gets Fast-track Status For FDA Review.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
